caffeine has been researched along with cannabidiol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Antonioli, R; Bonan, CD; Capiotti, KM; Crippa, JA; da Silva, RS; Hallak, JE; Nazario, LR; Zuardi, AW | 1 |
| López Hill, X; Nadal, X; Prieto, JP; Sanchez, V; Scorza, C; Urbanavicius, J | 1 |
| Church, RJ; Knappertz, V; Li, J; Watkins, PB | 1 |
| Critchley, D; Tayo, B; Thai, C | 1 |
| Fatarova, M; Guy, PA; Hoeng, J; Ivanov, NV; Kuczaj, A; Laszlo, C; Majeed, S; Mazurov, A; Pak, C; Peitsch, MC; Steiner, S; Vidal-de-Miguel, G; Zivkovic Semren, T | 1 |
| Bansal, S; Paine, MF; Spindle, TR; Thummel, KE; Unadkat, JD; Vandrey, R; Weerts, EM; Zamarripa, CA | 1 |
2 trial(s) available for caffeine and cannabidiol
| Article | Year |
|---|---|
Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical Trial.
Topics: Adult; Alanine Transaminase; Caffeine; Cannabidiol; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Drug Interactions; Female; Humans; Male | 2021 |
A Phase 1 Open-Label, Fixed-Sequence Pharmacokinetic Drug Interaction Trial to Investigate the Effect of Cannabidiol on the CYP1A2 Probe Caffeine in Healthy Subjects.
Topics: Adult; Anticonvulsants; Caffeine; Cannabidiol; Central Nervous System Stimulants; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Drug Interactions; Female; Humans; Male; Theophylline; Young Adult | 2021 |
5 other study(ies) available for caffeine and cannabidiol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio).
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Avoidance Learning; Behavior, Animal; Caffeine; Cannabidiol; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Memory Disorders; Motor Activity; Receptor, Adenosine A2A; Zebrafish | 2015 |
Cannabidiol Prevents the Expression of the Locomotor Sensitization and the Metabolic Changes in the Nucleus Accumbens and Prefrontal Cortex Elicited by the Combined Administration of Cocaine and Caffeine in Rats.
Topics: Animals; Behavior, Animal; Caffeine; Cannabidiol; Central Nervous System Stimulants; Cocaine; Electron Transport Complex IV; Locomotion; Nucleus Accumbens; Prefrontal Cortex; Rats | 2020 |
Application of Secondary Electrospray Ionization Coupled with High-Resolution Mass Spectrometry in Chemical Characterization of Thermally Generated Aerosols.
Topics: Aerosols; Azithromycin; Caffeine; Cannabidiol; Hydroxychloroquine; Melatonin; Spectrometry, Mass, Electrospray Ionization; Vitamin B 12 | 2022 |
Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants.
Topics: Adult; Caffeine; Cannabidiol; Cannabinoids; Cannabis; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dronabinol; Drug Interactions; Hallucinogens; Humans; Losartan; Midazolam; Omeprazole; Plant Extracts | 2023 |